Mortality risk among sulfonylureas: a systematic review and network meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mortality risk among sulfonylureas: a systematic review and network meta-analysis

Published:2015-01 Issue:1 Volume:3 Page:43-51
ISSN:2213-8587
Container-title:The Lancet Diabetes & Endocrinology
language:en
Short-container-title:The Lancet Diabetes & Endocrinology

Author:

Simpson Scot H,Lee Jayson,Choi Sabina,Vandermeer Ben,Abdelmoneim Ahmed S,Featherstone Travis R

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference74 articles.

1. Pharmacologic management of type 2 diabetes;Harper;Can J Diabetes,2013

2. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Inzucchi;Diabetes Care,2012

3. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33);Lancet,1998

4. Do sulfonylurea drugs increase the risk of cardiac events?;Bell;Can Med Assoc J,2006

5. Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction;Garratt;J Am Coll Cardiol,1999

Cited by 189 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glyburide use is associated with a greater likelihood of mortality or rehospitalization after acute coronary syndrome compared to gliclazide use in adults with type 2 diabetes: A cohort study;Diabetes, Obesity and Metabolism;2024-09-09

2. The place of gliclazide MB in modern treatment strategies for patients with type 2 diabetes mellitus;Diabetes mellitus;2024-09-04

3. Profiles of sulfonylurea use in Diabetes Mellitus type 2: an analysis of clinical practice over the last 10 years;Diabetes Research and Clinical Practice;2024-08

4. Current Position of Gliclazide and Sulfonylureas in the Contemporary Treatment Paradigm for Type 2 Diabetes: A Scoping Review;Diabetes Therapy;2024-06-27

5. Progress toward universal health coverage in Vietnam: Evidence on dispensing trends of diabetes medications from 2015 to 2021;Diabetes Research and Clinical Practice;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3